Navigation Links
Benefit of targeted lung cancer therapy confirmed
Date:6/3/2011

AURORA, Colo. (June 3, 2011) A drug that targets a specific type of lung cancer shows a dramatic response in more than half of the people who take it. The drug, called crizotinib, has been in clinical trials since 2006, and the results from the largest group of patients to take it within the first of these clinical trials are being presented at the annual meeting of the American Society of Clinical Oncology (ASCO).

The patients taking crizotinib have anaplastic lymphoma kinase (ALK) positive advanced non-small cell lung cancer (NSCLC) and the drug targets the gene that drives this particular kind of cancer. In 119 patients, crizotinib produces some degree of shrinkage in the tumors of the majority of patients with dramatic responses in more than 60 percent of cases. The responses last approximately 48 weeks.

D. Ross Camidge, MD, PhD, the director of the lung cancer clinical program at University of Colorado Hospital (UCH) and the University of Colorado Cancer Center, will be presenting the latest results from the crizotinib trial at ASCO. "The strength of crizotinib in ALK positive lung cancer was apparent when less than 20 patients were taking part in the trial. The benefit of targeting this kind of cancer with this particular drug has only been confirmed as more patients enrolled in the trial," said Camidge. "This demonstrates the efficacy of new drugs can be reliably revealed even among small groups of patients when the cancers being tested are molecularly uniform."

Medical oncologists at UCH care for one of the largest groups of ALK positive lung cancer patients in the world. Approximately one in 20 lung cancer patients is ALK positive - their responses to crizotinib are dramatic, the side effects are usually mild and often improve over time.

Camidge believes the results being seen with crizotinib open the door to a new way of thinking when it comes to cancer treatment. "We need to continue testing drugs in mole
'/>"/>

Contact: Erika Matich
erika.matich@ucdenver.edu
720-848-7852
University of Colorado Denver
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Mechanism discovered for health benefit of green tea, new approach to autoimmune disease
2. Radiology benefit managers adversely affect referring physicians, study suggests
3. Acupuncture of benefit to those with unexplained symptoms
4. Trial Stopped After Niacin Brings No Benefit to Heart Patients
5. CT angiography for low-risk heart patients leads to more drugs and tests without benefit
6. CT Heart Scans No Benefit to Patients Without Symptoms
7. Cancer Patients Benefit From Full Access to Medical Records
8. Enlarged prostate: Study demonstrates immediate and long-term benefits of laser treatment
9. Half of prostate cancers could potentially benefit from new type of cancer drugs, U-M study finds
10. Hospitals misleading patients about benefits of robotic surgery, study suggests
11. Selenium Supplements Might Give Modest Benefit Against Cholesterol
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/14/2014)... treat children with uncomplicated acute appendicitis is a reasonable ... fewer missed school days, according to a pilot study. ... Hospital and published online April 12 in the ... the first prospective study on nonoperative management of acute ... , Researchers enrolled 77 patients age 7 to 17 ...
(Date:4/14/2014)... 2014, Perth, Australia. Drug discovery company Proteomics International ... of a companion diagnostic (CDx) test with the ... The research team authenticated the panel of biomarkers ... samples. Seven biomarkers were validated at high stringency ... The mass spectrometry data was then cross-validated using ...
(Date:4/14/2014)... 2014) When it comes to the cost and ... Patients get the best care when they are treated ... extensive experience in their current job, according to a ... and Columbia Business School. The study was published in ... Applied Economics . , The review of more ...
(Date:4/13/2014)... STANFORD, Calif. A low-cost empowerment program for ... and sexual harassment of these girls, who live ... and are frequently attacked, a large new study ... Stanford University School of Medicine, Lucile Packard Children,s ... No Worldwide, validated the program,s effectiveness in combating ...
(Date:4/11/2014)... the processes that control brain cell production could pave ... brain-related disorders. , Scientists have gained new understanding of ... how and when nerve and brain cells are formed ... and keeps it healthy. Their findings could help explain ... which is a fundamental characteristic of many diseases including ...
Breaking Medicine News(10 mins):Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 2Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 3Health News:Longer nurse tenure on hospital units leads to higher quality care 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 3Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 4
... Could one day lead to treatments for baldness, researchers ... have taken a step forward in understanding the mechanisms ... some women, for all of history: hair loss. , ... hair follicles to start the hair-growing cycle. , "These ...
... Mylan Inc. (NYSE: MYL ),today announced that ... company has declared its quarterly dividend of $16.25 per,share ... a liquidation,preference of $1,000.00 per share) payable on August ... of August 1, 2008., Mylan Inc., with operations ...
... ATRC ), a medical device company and a leader in ... following,investor conferences during August:, -- The BMO Focus on ... the Millennium Broadway Hotel in New York. David J. Drachman, President ... present at 9:00 a.m. Eastern time., ...
... State of Michigan to spray the state,s apple orchards ... antibiotic to treat blood infections in newborns and other ... of America (IDSA). , The Environmental Protection Agency ... permission to use gentamicin to fight a tree disease ...
... Pat Phalin learned she had hearing loss at 30, ... school. The pupils heard sounds she could not hear. ... in his wife,s family history. Her mother, grandfather and great-grandfather ... children had hearing problems before he reached school age. ...
... 31, 2008 The AMERIGROUP Foundation, the,philanthropic arm ... for Children,s (UMHC) Breathmobile at a ceremony today ... Maryland Chief Operating Officer Vince Ancona presented a,contribution ... the AMERIGROUP,Foundation. The UMHC Breathmobile is a custom-built ...
Cached Medicine News:Health News:Mouse Study Finds Molecule That Tells Hair to Grow 2Health News:AtriCure to Present at the BMO Focus on Healthcare and Canaccord Adams Global Growth Conferences in August 2Health News:Physicians ask EPA, 'Antibiotics to cure sick apples, or sick children?' 2Health News:Inherited form of hearing loss stems from gene mutation 2Health News:Inherited form of hearing loss stems from gene mutation 3Health News:The AMERIGROUP Foundation Honors the University of Maryland Hospital for Children's Breathmobile 2
(Date:1/15/2014)... 15, 2014  Research and Markets ( http://www.researchandmarkets.com/research/6k27gw/dental ... "Dental Consumables Market - Global Industry Analysis, Size, ... report to their offering. ... Dental consumables are products which are used on ... tooth restoration and in treatment of associated gingival ...
(Date:1/15/2014)... LAWRENCEVILLE, N.J. , Jan. 15, 2014  Celsion ... today announced that it has received commitments from ... $15 million of the Company,s common stock in ... dedicated health care fund. The Company ... pursuant to which the Company agreed to sell ...
(Date:1/15/2014)... -- BreedIT Corp (OTC: BRDT), through its ... highly sophisticated agro-breeding solutions for plant breeders and researchers, ... board of directors appointed chemistry and pharmaceutical industry expert ... of the board. From 1975 to 2012, ... Ltd (NYSE: TEVA ) and its subsidiaries ...
Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3
... 2011 Hospira, Inc. (NYSE: HSP ), a ... that it will host a conference call to discuss its ... a.m. Central time. The company will release its ... open and the conference call. A live webcast ...
... DEL REY, Calif., April 4, 2011 Dr. Richard Merkin, ... official launch of the $3 million dollar Heritage Health Prize, ... celebrating the launch of the contest at the Data 2.0 ... interest in data mining and analytics to enter the $3 ...
Cached Medicine Technology:Heritage Provider Network Announces the Official Launch of the $3 million Dollar Heritage Health Prize 2Heritage Provider Network Announces the Official Launch of the $3 million Dollar Heritage Health Prize 3
... TC-PLUS Solution tricompartmental total knee prosthesis stems ... arthroplasty. State-of-the-art design and manufacturing technologies have ... biomechanical function as well as a favorable ... insert to keep wear to a minimum. ...
... The TC-PLUS Solution tricompartmental total knee prosthesis ... knee arthroplasty. State-of-the-art design and manufacturing technologies ... optimum biomechanical function as well as a ... tibial insert to keep wear to a ...
... Knee System is a long term, quality ... Available in both posterior stabilized and anatomically ... System provides the flexibility needed to address ... ease of identification keeps the user in ...
... a long term, quality solution based on ... posterior stabilized and anatomically correct cruciate retaining ... flexibility needed to address patients' needs. In ... keeps the user in mind and promotes ...
Medicine Products: